Evidence map›Paper›PMID 32511855›Full record

ArticleAngewandte Chemie (International ed. in English)2020

Pd-Senphos Catalyzed trans-Selective Cyanoboration of 1,3-Enynes.

Yuanzhe Zhang, Bo Li, Shih-Yuan Liu

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Synthesis and Characterization of anInorganic chemistry · 2026
    Article
  2. Article
  3. Article
  4. Borataalkenes, boraalkenes, and the ηChemical Society reviews · 2024
    Review
  5. Article
  6. Article
  7. Journal of the American Chemical Society · 2023
    Article
  8. AChemical science · 2023
    Article
  9. Mechanism of Pd/Senphos-CatalyzedThe Journal of organic chemistry · 2023
    Article
  10. Article
  11. The Rise of 1,4-BN-Heteroarenes: Synthesis, Properties, and Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Review
  12. Article
  13. C-Boron Enolates Enable Palladium Catalyzed Carboboration of Internal 1,3-Enynes.Angewandte Chemie (International ed. in English) · 2021
    Article
  14. Selectivity in the Elaboration of Bicyclic Borazarenes.Advanced synthesis & catalysis · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yuanzhe ZhangDepartment of Chemistry, Boston College, Chestnut Hill, MA, 02467-3860, USA.
Bo LiDepartment of Chemistry, Boston College, Chestnut Hill, MA, 02467-3860, USA.
Shih-Yuan LiuDepartment of Chemistry, Boston College, Chestnut Hill, MA, 02467-3860, USA.ORCID 0000-0003-3148-9147

Funding

Development of BN Heterocycles for Biomedical ResearchR01GM094541 · NIGMS · UNIVERSITY OF OREGON · PI LIU, SHIH-YUAN · 2010 to 2019
$2.8M
NIGMS NIH HHS R01 GM094541
6 · The paper itself

Abstract

The first trans-selective cyanoboration reaction of an alkyne, specifically a 1,3-enyne, is described. The reported palladium-catalyzed cyanoboration of 1,3-enynes is site-, regio-, and diastereoselective, and is uniquely enabled by the 1,4-azaborine-based Senphos ligand structure. Tetra-substituted alkenyl nitriles are obtained providing useful boron-dienenitrile building blocks that can be further functionalized. The utility of our method has been demonstrated with the synthesis of Satigrel, an anti-platelet aggregating agent.

Indexed as

BoranesCatalysisCyanidesDensity Functional TheoryFatty Acids, MonounsaturatedHydrocarbonsPalladiumPlatelet Aggregation InhibitorsStereoisomerismBoranesCyanidesFatty Acids, MonounsaturatedHydrocarbonsPalladiumPlatelet Aggregation InhibitorsSatigrelazaborineenynepalladiumtrans-cyanoboration

Identifiers

PMID32511855
PMCPMC7491284

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.